Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125558951 | 12555895 | 1 | I | 20160628 | 20160628 | 20160714 | 20160714 | EXP | TW-JUBILANT GENERICS LIMITED-1055043 | JUBILANT | JOURNAL: SINGAPORE MED J (DOI: 10.11622/SMEDJ.2016094)?AUTHOR: LEE YF, MAO WC, TAI YM, ET AL.?TITLE: DELAYED-ONSET RHABDOMYOLYSIS RELATED TO OLANZAPINE: A CASE REPORT?VOLUME: 57(5) YEAR: 2016 PAGES: 279 | 62.00 | YR | M | Y | 0.00000 | 20160714 | OT | TW | TW |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125558951 | 12555895 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | 200221 | ||||||||||||
125558951 | 12555895 | 2 | SS | BENZHEXOL HYDROCHLORIDE | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | 0 | ||||||||||||
125558951 | 12555895 | 3 | SS | ESTAZOLAM. | ESTAZOLAM | 1 | 0 | ||||||||||||
125558951 | 12555895 | 4 | SS | VALPROATE | VALPROIC ACID | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125558951 | 12555895 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125558951 | 12555895 | Paralysis | |
125558951 | 12555895 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |